Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Interpace Diag Group (IDXG)

Interpace Diag Group (IDXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 13,536
  • Shares Outstanding, K 4,230
  • Annual Sales, $ 41,310 K
  • Annual Income, $ -14,940 K
  • 60-Month Beta 1.19
  • Price/Sales 0.35
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade IDXG with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.19
  • Most Recent Earnings -0.52 on 05/16/22
  • Next Earnings Date 08/09/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.52
  • Number of Estimates 1
  • High Estimate -0.52
  • Low Estimate -0.52
  • Prior Year -0.83
  • Growth Rate Est. (year over year) +37.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.8000 +14.29%
on 06/17/22
3.6000 -11.11%
on 06/06/22
-0.1000 (-3.03%)
since 06/01/22
3-Month
2.7550 +16.15%
on 05/16/22
5.2000 -38.46%
on 04/08/22
-1.8000 (-36.00%)
since 04/01/22
52-Week
2.7550 +16.15%
on 05/16/22
10.5100 -69.55%
on 07/02/21
-7.2000 (-69.23%)
since 07/01/21

Most Recent Stories

More News
XpresSpa Group, Inc. (XSPA) Reports Q1 Loss, Tops Revenue Estimates

XpresSpa Group, Inc. (XSPA) delivered earnings and revenue surprises of 33.33% and 23.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

XSPA : 0.6984 (+1.14%)
IDXG : 3.2000 (-6.43%)
Interpace Biosciences Announces First Quarter 2022 Financial and Business Results

 ●Q1 Revenue of $10.4 million up 6% versus Prior Year ●Q1 Net Loss improved $2 million versus Prior Year ●Days Sales Outstanding (DSO) decreased by 27% ...

IDXG : 3.2000 (-6.43%)
Organon (OGN) Q1 Earnings and Revenues Beat Estimates

Organon (OGN) delivered earnings and revenue surprises of 25.95% and 3.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OGN : 34.25 (+1.48%)
IDXG : 3.2000 (-6.43%)
Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business Results

 ●2021 Full Year Net Revenue of $41.3 Million up 28% vs Prior Year; Fourth Quarter Net Revenue of $10.9 Million up 13% vs Prior Year  ●2021 Full Year Net...

IDXG : 3.2000 (-6.43%)
Assure Holdings Corp. (IONM) Reports Q4 Loss, Tops Revenue Estimates

Assure Holdings Corp. (IONM) delivered earnings and revenue surprises of -50% and 8.53%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

IONM : 1.4727 (+0.87%)
IDXG : 3.2000 (-6.43%)
LifeMD, Inc. (LFMD) Reports Q4 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 25.64% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

LFMD : 2.07 (+1.47%)
IDXG : 3.2000 (-6.43%)
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests

PARSIPPANY, NJ, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling...

IDXG : 3.2000 (-6.43%)
Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director

PARSIPPANY, NJ, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (OTCQX: IDXG) (“Interpace”) a leader in enabling personalized medicine, is...

IDXG : 3.2000 (-6.43%)
Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights Offering

PARSIPPANY, NJ, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it...

IDXG : 3.2000 (-6.43%)
Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights Offering

Proceeds to be used to fund the organic growth and prospective product line acquisitions PARSIPPANY, NJ, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Interpace...

IDXG : 3.2000 (-6.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 3.7500
2nd Resistance Point 3.6000
1st Resistance Point 3.4000
Last Price 3.2000
1st Support Level 3.0500
2nd Support Level 2.9000
3rd Support Level 2.7000

See More

52-Week High 10.5100
Fibonacci 61.8% 7.5476
Fibonacci 50% 6.6325
Fibonacci 38.2% 5.7174
Last Price 3.2000
52-Week Low 2.7550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar